HBK INVESTMENTS L P - THERAVANCE BIOPHARMA INC ownership

Quarter-by-quarter ownership
HBK INVESTMENTS L P ownership history of THERAVANCE BIOPHARMA INC
ValueSharesWeighting
Q2 2022$44,830,000
+17.5%
48,455,000
+21.3%
0.25%
+58.8%
Q1 2022$38,147,000
+15.5%
39,945,000
+16.8%
0.16%
+30.1%
Q4 2021$33,023,000
+58.5%
34,195,000
+52.0%
0.12%
+50.0%
Q3 2021$20,832,00022,500,0000.08%
Other shareholders
THERAVANCE BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Context Capital Management, LLC 25,388$23,544,0002.40%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 49,675,000$46,013,0001.22%
DeepCurrents Investment Group LLC 33,824,000$31,165,0000.93%
Aequim Alternative Investments LP 13,920,000$12,909,0000.50%
Maven Securities LTD 14,280,000$14,280,0000.46%
Saltoro Capital, LP 1,350,000$1,252,0000.44%
Baupost Group 30,000,000$27,640,0000.25%
TENOR CAPITAL MANAGEMENT Co., L.P. 5,500,000$5,182,0000.12%
ZAZOVE ASSOCIATES LLC 1,250,000$1,163,0000.10%
HBK INVESTMENTS L P 22,500,000$20,832,0000.08%
View complete list of THERAVANCE BIOPHARMA INC shareholders